Werkgroep Cardiologische centra Nederland

ATLAS-2 (Completed)

A Randomized, Double-Blind, Placebo-Controlled, Event-Driven Multicenter Study to Evaluate the Efficacy and Safety of Rivaroxaban in Subjects With a Recent Acute Coronary Syndrome
Medicine
rivaroxaban
Population
ASCVD
Phase
III
Starting year
2009
More information
ClinicalTrials.gov

Contact

dr. M.W.J. van Hessen (Cardioloog)
Gouda, Groene Hart Ziekenhuis

ATLAS-2: News